Presenter's Information
Kyung Woo Park, MD
Country | Korea (Republic of) |
Specialty | Interventional Cardiologist |
- Modulation of DAPT Duration: What is the Best?
- P2Y12 Inhibitor or Asprin for Long-term Antiplatelet Management
- The Optimal Antithrombotic Strategy in Patients with AF and ACS: Focusing on the AUGUSTUS Trial
- Toolbox for Bleeding/Ischemic Risk Scores in ACS/PCI: How Do We Select Best One?
- Optimal Choice of Antiplatelet Therapy in Asian Patients
- Safety and Efficacy of Biolimus-Eluting Stents: Real World Experience from Korea
- Safety and Efficacy of DES: Evidence from a Network Meta-Analysis
- Statin for Better Outcome in Patients with ACS
- Achieve Best Controls with Fixed Dose Combination for High Blood Pressure
- The Art of Balance in Clopidogrel: Efficacy vs. Safety
- Safety and Efficacy of Second-Generation Stents in Real-World Practice
- The Ideal Patient Types for the Different Antiplatelet Agents
- Cilostazol as a Solution for Patients with Genetic Risk of Antiplatelet Therapy Resistance: Insights from the CILON-T Trial
- BioMatrixTM: The Next Generation Biodegradable Polymer Technology - Korean Experience
- Is It Real? Cytochrome P450 Genetic Polymorphisms, Varying Response to Clopidogrel, and Link to Clinical Outcomes : Korean Perspective